We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$229M
Cap. Flow %
-1.35%
Top 10 Hldgs %
33.75%
Holding
1,490
New
144
Increased
706
Reduced
317
Closed
73

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$448M
2
AMT icon
American Tower
AMT
+$132M
3
HIW icon
Highwoods Properties
HIW
+$92.2M
4
WELL icon
Welltower
WELL
+$79.2M
5
PLD icon
Prologis
PLD
+$71.1M

Sector Composition

Rank Sector Weight
1 Real Estate 60.4%
2 Technology 9.49%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OYST
1351
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$1K ﹤0.01%
+76
New +$964
CLVS
1352
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
406
AKUS
1353
DELISTED
Akouos Inc
AKUS
$1K ﹤0.01%
65
AERI
1354
DELISTED
Aerie Pharmaceuticals
AERI
$1K ﹤0.01%
102
RDUS
1355
DELISTED
Radius Health, Inc.
RDUS
$1K ﹤0.01%
88
BDSI
1356
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1K ﹤0.01%
222
ADVM
1357
DELISTED
Adverum Biotechnologies
ADVM
$0 ﹤0.01%
18
ALV icon
1358
Autoliv
ALV
$9.04B
-3,750
Closed -$321K
ANIP icon
1359
ANI Pharmaceuticals
ANIP
$1.83B
-27
Closed -$1K
APLT
1360
DELISTED
Applied Therapeutics
APLT
$0 ﹤0.01%
42
APO icon
1361
Apollo Global Management
APO
$71.3B
-8,600
Closed -$530K
APRE icon
1362
Aprea Therapeutics
APRE
$7.68M
-2
Closed
ARDX icon
1363
Ardelyx
ARDX
$1.25B
-196
Closed
ASMB icon
1364
Assembly Biosciences
ASMB
$511M
-6
Closed
OPTU
1365
Optimum Communications Inc
OPTU
$296M
-15,047
Closed -$312K
AUTL
1366
Autolus Therapeutics
AUTL
$383M
$0 ﹤0.01%
74
AVAV icon
1367
AeroVironment
AVAV
$7.84B
-625
Closed -$54K
BE icon
1368
Bloom Energy
BE
$48B
-212,800
Closed -$3.98M
CABA icon
1369
Cabaletta Bio
CABA
$442M
$0 ﹤0.01%
45
CGNT icon
1370
Cognyte Software
CGNT
$655M
-4,195
Closed -$86K
CHGG icon
1371
Chegg
CHGG
$121M
-1,555
Closed -$106K
CLLS
1372
Cellectis
CLLS
$283M
$0 ﹤0.01%
40
CNTB
1373
Connect Biopharma Holdings
CNTB
$130M
-6,069
Closed -$147K
CTMX icon
1374
CytomX Therapeutics
CTMX
$694M
$0 ﹤0.01%
102
DNTH icon
1375
Dianthus Therapeutics
DNTH
$5.57B
$0 ﹤0.01%
7

Similar funds

Daiwa Securities Group's Q4 2021 Portfolio in Review

As of Q4 2021, Daiwa Securities Group held 1,490 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q4 2021 filing shows 144 new, 706 increased, 317 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M. The largest sale was VEREIT, Inc., an estimated $434M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M.
  • Daiwa Securities Group added most to Realty Income in Q4 2021, an estimated $448M increase.
  • Daiwa Securities Group's biggest Q4 2021 reduction was CyrusOne Inc Common Stock, cutting an estimated $386M.
  • Daiwa Securities Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $434M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $17B portfolio in Q4 2021.
  • Daiwa Securities Group opened 144 new positions and closed 73 in Q4 2021.
  • Daiwa Securities Group's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.